Rocket Pharmaceuticals, Inc.
RCKT
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.58% | 4.20% | -12.23% | -4.01% | 3.62% |
| Total Depreciation and Amortization | -1.17% | 0.76% | 5.19% | 16.49% | 10.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.92% | 3.40% | 21.23% | 15.46% | -27.33% |
| Change in Net Operating Assets | -125.35% | -35.17% | 195.78% | -120.80% | 468.30% |
| Cash from Operations | 9.91% | 3.20% | 5.33% | -93.79% | 48.66% |
| Capital Expenditure | 80.54% | 17.72% | 5.16% | 56.21% | 0.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -146.66% | 39.88% | 55.26% | 127.22% | -357.34% |
| Cash from Investing | -147.99% | 41.88% | 58.77% | 124.88% | -391.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 103,791.48% | -88.50% | 29.22% | 202.81% | -99.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103,791.48% | -88.50% | 29.22% | 202.81% | -99.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.20% | 710.33% | 116.14% | 87.84% | -194.00% |
